Supernus Pharmaceuticals SUPN Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Supernus Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation?
- Supernus Pharmaceuticals (SUPN) reported cash provided by (used in) investing activity, including discontinued operation of -$19.22M in Q1 2026.
- How has Supernus Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Supernus Pharmaceuticals's cash provided by (used in) investing activity, including discontinued operation decreased by 151.5% year-over-year, from $37.32M to -$19.22M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.